Want to see BOLD full AI Analyst Report?
Total Valuation
Boundless Bio Inc. has a market cap or net worth of $56.19M. The enterprise value is $62.25M.
Market Cap$56.19M
Enterprise Value$62.25M
Share Statistics
Boundless Bio Inc. has 22,474,777 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,474,777
Owned by Insiders14.66%
Owned by Institutions8.90%
Financial Efficiency
Boundless Bio Inc.’s return on equity (ROE) is -0.59 and return on invested capital (ROIC) is -43.03%.
Return on Equity (ROE)-0.59
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-43.03%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee0.00
Profits Per Employee-909.33K
Employee Count64
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Boundless Bio Inc. is ―. Boundless Bio Inc.’s PEG ratio is 0.01.
PE Ratio―
PS Ratio0.00
PB Ratio0.27
Price to Fair Value0.27
Price to FCF-0.57
Price to Operating Cash Flow-1.19
PEG Ratio0.01
Income Statement
In the last 12 months, Boundless Bio Inc. had revenue of 0.00 and earned -58.20M in profits. Earnings per share was -2.60.
Revenue0.00
Gross Profit-1.25M
Operating Income-63.55M
Pretax Income-58.20M
Net Income-58.20M
EBITDA-56.95M
Earnings Per Share (EPS)-2.60
Cash Flow
In the last 12 months, operating cash flow was -47.10M and capital expenditures -495.00K, giving a free cash flow of -47.60M billion.
Operating Cash Flow-47.10M
Free Cash Flow-47.60M
Free Cash Flow per Share-2.12
Dividends & Yields
Boundless Bio Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.50
52-Week Price Change129.36%
50-Day Moving Average1.63
200-Day Moving Average1.32
Relative Strength Index (RSI)77.02
Average Volume (3m)178.65K
Important Dates
Boundless Bio Inc. upcoming earnings date is Aug 17, 2026, Before Open (Confirmed).
Last Earnings DateMay 8, 2026
Next Earnings DateAug 17, 2026
Ex-Dividend Date―
Financial Position
Boundless Bio Inc. as a current ratio of 8.74, with Debt / Equity ratio of 55.90%
Current Ratio8.74
Quick Ratio8.74
Debt to Market Cap0.00
Net Debt to EBITDA-0.55
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Boundless Bio Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Boundless Bio Inc. EV to EBITDA ratio is -1.02, with an EV/FCF ratio of -1.23.
EV to Sales0.00
EV to EBITDA-1.02
EV to Free Cash Flow-1.23
EV to Operating Cash Flow-1.24
Balance Sheet
Boundless Bio Inc. has $92.85M in cash and marketable securities with $48.29M in debt, giving a net cash position of $44.56M billion.
Cash & Marketable Securities$92.85M
Total Debt$48.29M
Net Cash$44.56M
Net Cash Per Share$1.98
Tangible Book Value Per Share$4.41
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Boundless Bio Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast15.42%